Acknowledgment
The editors and the publisher would like to thank the members of the Editorial Board and the following colleagues for their kind assistance in reviewing articles submitted to Drug Metabolism and Personalized Therapy in 2016.[*]
Adam de Beaumais, Tiphaine
Alves, Gilberto
Arullappan, Sangeetha
Baldoni, Andre
Chauhan, Hiteshi K.C.
Cottney, Alan
Das, Reena
De Andrés, Fernando
Devínsky, Ferdinand
Dorado, Pedro
Dunnenberger, Henry M.
Fabbri, Chiara
Garcia-Orad, A.
González-Naranjo, Maria
Haga, Susanne B.
Hanci, Volkan
Hashemi, Mohammad
Hirata, Rosario
Iyer, Krishna
Jacobs, Clifford
Juárez, Hugo
Kawedia, Jitesh D.
Kohlrausch, Fabiana B.
Kovac, Mirjana
Kurtz, Guilherme
López, Marisol
Luis, López-Fernández
Marc, Maliepaard
Moes, D.J.A.R.
Montane, Lazara
Mosquera, Laura Muino
Navarra, Pierluigi
Normanno, Nicola
Owira, Peter
Pals, Gerard
Patrinos, George
Poi, Ming
Ragia, Georgia
Ramesh, Jagat Kanwar
Salazar, Juliana
Satyanarayana, Rao
Serretti, Alessandro
Skowron, Monika
Soares, Fernanda
Sosa-Macías, Martha
Sukasem, Chonlaphat
Tomaszewski, Piotr
Uppugunduri, Chakradhara
van der Bijl, Pieter
Yamsani, Madhusudan
Yap, C.K.
Zarzycki, Pawel K.
©2016 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Editorial
- The Santorini Conferences continue
- Mini Reviews
- CYP2D6 variability in populations from Venezuela
- Can pharmacogenetics help patients under chronic treatment with coumarin anticoagulants?
- Pharmacogenetic studies: a tool to improve antidepressant therapy
- Original Articles
- 1846G>A polymorphism of CYP2D6 gene and extrapyramidal side effects during antipsychotic therapy among Russians and Tatars: a pilot study
- SLC22A2 – mapping genomic variations within South African indigenous and admixed populations
- Improvement of the chemical inhibition phenotyping assay by cross-reactivity correction
- Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition
- Case Report
- Vancomycin-induced thrombocytopenia in a newborn
- Acknowledgment
- Acknowledgment
- Congress Abstracts
- 8th Santorini Conference Systems Medicine and Personalised Health and Therapy
Artikel in diesem Heft
- Frontmatter
- Editorial
- The Santorini Conferences continue
- Mini Reviews
- CYP2D6 variability in populations from Venezuela
- Can pharmacogenetics help patients under chronic treatment with coumarin anticoagulants?
- Pharmacogenetic studies: a tool to improve antidepressant therapy
- Original Articles
- 1846G>A polymorphism of CYP2D6 gene and extrapyramidal side effects during antipsychotic therapy among Russians and Tatars: a pilot study
- SLC22A2 – mapping genomic variations within South African indigenous and admixed populations
- Improvement of the chemical inhibition phenotyping assay by cross-reactivity correction
- Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition
- Case Report
- Vancomycin-induced thrombocytopenia in a newborn
- Acknowledgment
- Acknowledgment
- Congress Abstracts
- 8th Santorini Conference Systems Medicine and Personalised Health and Therapy
